Default company panoramic image

Stella Therapeutics

Stella Therapeutics drugs hold the potential to cure the brain cancer, Glioblastoma Multiforme, while maintaining patient quality of life.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Seattle, WA, USA
  • Currency USD
  • Founded March 2011
  • Employees 2
  • Website

Company Summary

Current standard of care for the aggressive brain cancer Glioblastoma multiforme (GBM) only increases survival by 7 months yet $1B in sales was generated to treat these patients. Stella Therapeutics is commercializing first-in-class small molecules (ST-drugs) that selectively kill GBM tumors through a novel mechanism of action that culminates with the induction of apoptosis (the cellular suicide pathway), while leaving healthy cells unharmed.


  • Default avatar
    Nephi Stella
    Founder and President

    Dr Nephi Stella is a Professor of Pharmacology at the University of Washington. He has over 25 years of experience studying neuro-oncology, neuro-inflammation, and neurodegeneration. Dr. Stella has published over 40 manuscripts and multiple patents and is regularly invited to speak at conferences around the world. He has leveraged these opportunities to build a global network in both the pharmaceutical industry and academia.

  • Default avatar
    Elwood Howse
    Board Member

    Mr. Howse has been a longtime adviser to Stella Therapeutics and joined the board in 2012. He is currently a Director at Capstone Therapeutics, and was the President and Co-Founder of Cable & Howse Ventures, which provided seed funding for Immunex and Zymogenetics, and was a Co-Founder of Cable, Howse and Ragen. He has served as a corporate director and adviser for various public, private, and non-profit ventures.

  • Default avatar
    Steve Mattioli
    Board Member

    Mr. Mattioli has been a longtime adviser to Stella Therapeutics and joined the board 2012. He has over 25 years’ experience in founding, managing and growing technology and biotech startup companies. Currently, President & CEO of Point of Data and previously Founder & CEO of YottaYotta, and CEO of SEEK Systems, he has held multiple senior management positions and corporate director and adviser for various public and private companies.


  • Default avatar
    John Steel, DLA Piper
    Default avatar
    Eric Kauppila, CPA, MS Tax